Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
15.97
+0.13 (0.82%)
Jan 30, 2025, 4:00 PM EST - Market closed
Organon & Co. Market Cap
Organon & Co. has a market cap or net worth of $4.11 billion as of January 30, 2025. Its market cap has decreased by -3.01% in one year.
Market Cap
4.11B
Enterprise Value
12.10B
1-Year Change
-3.01%
Ranking
Category
Stock Price
$15.97
Market Cap Chart
Since May 14, 2021, Organon & Co.'s market cap has decreased from $8.42B to $4.11B, a decrease of -51.13%. That is a compound annual growth rate of -17.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2025 | 4.11B | 7.04% |
| Dec 31, 2024 | 3.84B | 4.25% |
| Dec 29, 2023 | 3.69B | -48.12% |
| Dec 30, 2022 | 7.10B | -7.98% |
| Dec 31, 2021 | 7.72B | -8.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 724.84B |
| UnitedHealth Group | 499.24B |
| Novo Nordisk | 378.93B |
| Johnson & Johnson | 362.06B |
| AbbVie | 308.91B |
| Merck & Co. | 246.51B |
| Thermo Fisher Scientific | 223.49B |
| Abbott Laboratories | 220.95B |